<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">ejols</journal-id><journal-title-group><journal-title xml:lang="en">The Eurasian Journal of Life Sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Евразийский журнал наук о жизни</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3033-5493</issn><issn pub-type="epub">3033-6031</issn><publisher><publisher-name>Сеченовский Университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47093/3033-5493.2025.1.1.53-72</article-id><article-id custom-type="elpub" pub-id-type="custom">ejols-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Treatment of cardiac contusion: experimental basis for pathogenetic therapy and emerging approaches in cardioprotection</article-title><trans-title-group xml:lang="ru"><trans-title>Лечение ушиба сердца: экспериментальные основы патогенетической терапии и новые подходы к кардиопротекции</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6775-323X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Золотов</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zolotov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Александр Николаевич Золотов, канд. мед. наук, доцент, старший научный сотрудник центральной научно-исследовательской лаборатории, доцент кафедры патофизиологии</p><p>644099, г. Омск, Ул. Ленина, д.12</p></bio><bio xml:lang="en"><p>Alexander N. Zolotov, PhD, Associate Professor, Senior Researcher of the Central Research Laboratory, Associate Professor of the Department of Pathophysiology</p><p>str. Lenina, 12, Omsk, 644099</p></bio><email xlink:type="simple">zolotov@omgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-2846-6711</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ли</surname><given-names>Ц.</given-names></name><name name-style="western" xml:lang="en"><surname>Li</surname><given-names>J.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цзяминь Ли, профессор, заместитель руководителя департамента</p><p>150088, Хэйлунцзян, г. Харбин, ул. Баоцзянь, д.157</p></bio><bio xml:lang="en"><p>Jiamin Li, PhD, Professor, Deputy Director of the Office</p><p>157 Baojian Rd, Nangang, Harbin, 150088, Heilongjiang</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7243-6968</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ван</surname><given-names>Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Wang</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нин Ван, профессор, заместитель директора</p><p>150088, пров. Хэйлунцзян, г. Харбин, ул. Баоцзянь, д.157</p></bio><bio xml:lang="en"><p>Ning Wang, PhD, Professor, Deputy director</p><p>157 Baojian Rd, Nangang, Harbin, 150088, Heilongjiang</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0063-3433</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Приймак</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Priymak</surname><given-names>A. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Антон Борисович Приймак, канд. мед. наук, ассистент кафедры патофизиологии</p><p>644099, г. Омск, ул. Ленина, д.1</p></bio><bio xml:lang="en"><p>Anton B. Priymak, PhD, Assistant of the Department of Pathophysiology</p><p>str. Lenina, 12, Omsk, 644099</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6110-3933</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корпачева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Korpacheva</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Валентиновна Корпачева, д-р. мед. наук, профессор, заведующий кафедрой патофизиологии</p><p>644099, г. Омск, ул. Ленина, д.12</p><p> </p></bio><bio xml:lang="en"><p>Olga V. Korpacheva, MD, DMSc, Professor, Head of the Department of Pathophysiology</p><p>str. Lenina, 12, Omsk, 644099</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4606-3173</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ключникова</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Klyuchnikova</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евгения Игоревна Ключникова, аспирант, ассистент кафедры патофизиологии</p><p>644099, г. Омск, ул. Ленина, д.12</p></bio><bio xml:lang="en"><p>Evgenia I. Klyuchnikova, PhD student, Assistant of the Department of Pathophysiology</p><p>str. Lenina, 12, Omsk, 644099</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-2096-5390</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торопов</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Toropov</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андрей Петрович Торопов, канд. мед. наук, ассистент кафедры патофизиологии</p><p>644099, г. Омск, ул. Ленина, д.12</p><p> </p></bio><bio xml:lang="en"><p>Andrei P. Toropov, PhD, Assistant of the Department of Pathophysiology</p><p>str. Lenina, 12, Omsk, 644099</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Омский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Omsk State Medical University</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Харбинский медицинский университет</institution></aff><aff xml:lang="en"><institution>Harbin Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>01</day><month>07</month><year>2025</year></pub-date><volume>1</volume><issue>1</issue><fpage>53</fpage><lpage>72</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Zolotov A.N., Li J., Wang N., Priymak A.B., Korpacheva O.V., Klyuchnikova E.I., Toropov A.P., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Золотов А.Н., Ли Ц., Ван Н., Приймак А.Б., Корпачева О.В., Ключникова Е.И., Торопов А.П.</copyright-holder><copyright-holder xml:lang="en">Zolotov A.N., Li J., Wang N., Priymak A.B., Korpacheva O.V., Klyuchnikova E.I., Toropov A.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.eajls.com/jour/article/view/7">https://www.eajls.com/jour/article/view/7</self-uri><abstract><p>Myocardial contusion is a serious consequence of blunt thoracic trauma, most commonly resulting from traffic accidents, falls, sports injuries, and combatrelated events. It is associated with impaired myocardial contractility, fibrosis, and systemic inflammation, and carries a high risk of complications, with mortality rates reaching up to 10%. Despite advances in understanding the pathogenesis, the development of effective therapeutic strategies remains a key priority in experimental cardiology. </p><p>A promising direction involves the development of targeted approaches that address both myocardial injury and the optimization of adaptive responses. The first aspect focuses on counteracting bioenergetic hypoxia, restoring energy and ionic homeostasis, suppressing secondary damage in the context of inflammation, and regulating apoptosis and autophagy. The second aspect targets the modulation of stress-activating and stress-limiting systems, including tissue-level adaptation mechanisms.</p><p>Particular attention has been given to cardioprotective agents, which have demonstrated efficacy in ischemic heart disease, myocardial infarction, and ischemia–reperfusion injury. However, their impact on post-traumatic myocardial remodeling remains insufficiently explored. Phytopreparations from the Chinese Pharmacopoeia, characterized by multitarget activity on key pathological processes — such as bioenergetic deficiency, oxidative stress, and dysregulation of cellular homeostasis — may offer a viable alternative. Integrated strategies combining anti-inflammatory effects, metabolic support, and control of fibrogenesis may enhance therapeutic outcomes.</p><p>Further research is necessary to assess the synergistic interactions of individual components, dose-dependent responses, and the long-term impact on myocardial structure and function. Multimodal approaches may improve therapeutic efficacy and help overcome the limitations of monotherapy, opening new avenues for the management of post-traumatic cardiac complications.</p></abstract><trans-abstract xml:lang="ru"><p>Ушиб сердца – серьёзное последствие тупой травмы грудной клетки, чаще всего возникающее в результате дорожно-транспортных происшествий, падений, спортивных травм и в ходе боевых действий. Это состояние сопровождается нарушением сократимости миокарда, фиброзом и системным воспалением, а также высоким риском осложнений, при этом летальность может достигать 10%. Несмотря на успехи в понимании патогенеза, разработка эффективных стратегий лечения остаётся ключевым приоритетом в экспериментальной кардиологии.</p><p>Перспективным направлением является разработка таргетных подходов, направленных как на лечение повреждения миокарда, так и на оптимизацию адаптивных реакций. Первый аспект фокусируется на противодействии биоэнергетической гипоксии, восстановлении энергетического и ионного гомеостаза, подавлении вторичного повреждения в условиях воспаления и регуляции апоптоза и аутофагии. Второй аспект направлен на модуляцию стресс-активирующих и стресс-лимитирующих систем, включая механизмы адаптации на тканевом уровне. Особое внимание уделяется кардиопротекторным препаратам, продемонстрировавшим эффективность при ишемической болезни сердца, инфаркте миокарда и реперфузионном синдроме. Однако их влияние на посттравматическое ремоделирование миокарда остается недостаточно изученным. Фитопрепараты китайской фармакопеи, характеризующиеся многоцелевым действием на ключевые патологические процессы, такие как биоэнергетический дефицит, окислительный стресс и нарушение регуляции клеточного гомеостаза, могут стать достойной альтернативой. Комплексные стратегии, сочетающие противовоспалительное действие, метаболическую поддержку и контроль фиброгенеза, могут улучшить результаты терапии.</p><p>Необходимы дальнейшие исследования для оценки синергического взаимодействия отдельных компонентов, дозозависимых ответов и долгосрочного влияния на структуру и функцию миокарда. Мультимодальные подходы могут повысить терапевтическую эффективность и помочь преодолеть ограничения монотерапии, открыв тем самым новые возможности для лечения посттравматических кардиологических осложнений</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ушиб сердца</kwd><kwd>тупая травма сердца</kwd><kwd>тупое повреждение сердца</kwd><kwd>тупая травма грудной клетки</kwd><kwd>контузия сердца</kwd><kwd>кардиопротекция</kwd><kwd>системы активации стресса</kwd><kwd>системы подавления стресса</kwd></kwd-group><kwd-group xml:lang="en"><kwd>commotio cordis</kwd><kwd>blunt cardiac trauma</kwd><kwd>blunt cardiac injury</kwd><kwd>blunt chest trauma</kwd><kwd>heart contusion</kwd><kwd>cardioprotection</kwd><kwd>stress-activating systems</kwd><kwd>stress-limiting systems</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Brewer B, Zarzaur BL. Cardiac Contusions. Current Trauma Reports. 2015;1:232- 236. https://doi.org/10.1007/s40719-015-0031-x.</mixed-citation><mixed-citation xml:lang="en">Brewer B, Zarzaur BL. Cardiac Contusions. Current Trauma Reports. 2015;1:232- 236. https://doi.org/10.1007/s40719-015-0031-x.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ždrale S, Vuković M. Cardiac War Wounds. Acta Facultatis Medicae Naissensis. 2016;33:135-140. https://doi.org/10.1515/afmnai-2016-0015.</mixed-citation><mixed-citation xml:lang="en">Ždrale S, Vuković M. Cardiac War Wounds. Acta Facultatis Medicae Naissensis. 2016;33:135-140. https://doi.org/10.1515/afmnai-2016-0015.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Huber S, Biberthaler P, Delhey P, et al. Predictors of poor outcomes after significant chest trauma in multiply injured patients: a retrospective analysis from the German Trauma Registry (Trauma Register DGU®). Scand J Trauma Resusc Emerg Med. 2014;22:52. https://doi.org/10.1186/s13049-014-0052-4.</mixed-citation><mixed-citation xml:lang="en">Huber S, Biberthaler P, Delhey P, et al. Predictors of poor outcomes after significant chest trauma in multiply injured patients: a retrospective analysis from the German Trauma Registry (Trauma Register DGU®). Scand J Trauma Resusc Emerg Med. 2014;22:52. https://doi.org/10.1186/s13049-014-0052-4.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Scagliola R, Seitun S, Balbi M. Cardiac contusions in the acute care setting: Historical background, evaluation and management. Am J Emerg Med. 2022;61:152-157. https://doi.org/10.1016/j.ajem.2022.09.005.</mixed-citation><mixed-citation xml:lang="en">Scagliola R, Seitun S, Balbi M. Cardiac contusions in the acute care setting: Historical background, evaluation and management. Am J Emerg Med. 2022;61:152-157. https://doi.org/10.1016/j.ajem.2022.09.005.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kyriazidis IP, Jakob DA, Vargas JAH, et al. Accuracy of diagnostic tests in cardiac injury after blunt chest trauma: a systematic review and meta-analysis. World J Emerg Surg. 2023;18(1):36. https://doi.org/10.1186/s13017-023-00504-9.</mixed-citation><mixed-citation xml:lang="en">Kyriazidis IP, Jakob DA, Vargas JAH, et al. Accuracy of diagnostic tests in cardiac injury after blunt chest trauma: a systematic review and meta-analysis. World J Emerg Surg. 2023;18(1):36. https://doi.org/10.1186/s13017-023-00504-9.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Baldwin D, Chow KL, Mashbari H, Omi E, Lee JK. Case reports of atrial and pericardial rupture from blunt cardiac trauma. J CardiothoracSurg. 2018;13(1):71. https://doi.org/10.1186/s13019-018-0753-2.</mixed-citation><mixed-citation xml:lang="en">Baldwin D, Chow KL, Mashbari H, Omi E, Lee JK. Case reports of atrial and pericardial rupture from blunt cardiac trauma. J CardiothoracSurg. 2018;13(1):71. https://doi.org/10.1186/s13019-018-0753-2.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Denisov AV, Kuzmin AYa, Gavrilin SV et al. Heart contusion in case of closed chest injuries: etiology, diagnosis, severity of heart damage (literature review). Military Medical Journal. 2018;339(8):24-32. (In Russ.). https://doi.org/10.17816/RMMJ73014.</mixed-citation><mixed-citation xml:lang="en">Denisov AV, Kuzmin AYa, Gavrilin SV et al. Heart contusion in case of closed chest injuries: etiology, diagnosis, severity of heart damage (literature review). Military Medical Journal. 2018;339(8):24-32. (In Russ.). https://doi.org/10.17816/RMMJ73014.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bordakov PV, Ostapenko EN, Bordakov VN, Gukailo SE, Ignatovich DV. Closed heart injuries. Diagnosis and treatment at the prehospital stage. Military medicine. 2023;1(66):2-12. (In Russ.). https://doi.org/10.51922/2074-5044.2023.1.2.</mixed-citation><mixed-citation xml:lang="en">Bordakov PV, Ostapenko EN, Bordakov VN, Gukailo SE, Ignatovich DV. Closed heart injuries. Diagnosis and treatment at the prehospital stage. Military medicine. 2023;1(66):2-12. (In Russ.). https://doi.org/10.51922/2074-5044.2023.1.2.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">McMullan MH, Maples MD, Kilgore TL Jr, Hindman SH. Surgical experience with left ventricular free wall rupture. Ann Thorac Surg. 2001;71(6):1894-1899. https://doi.org/10.1016/s0003-4975(01)02625-x.</mixed-citation><mixed-citation xml:lang="en">McMullan MH, Maples MD, Kilgore TL Jr, Hindman SH. Surgical experience with left ventricular free wall rupture. Ann Thorac Surg. 2001;71(6):1894-1899. https://doi.org/10.1016/s0003-4975(01)02625-x.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kang W, Robitaille MC, Merrill M, Teferra K, Kim C, Raphael MP. Mechanisms of cell damage due to mechanical impact: an in vitro investigation. Sci Rep. 2020;10(1):12009. Published 2020 Jul 20. https://doi.org/10.1038/s41598-020-68655-2.</mixed-citation><mixed-citation xml:lang="en">Kang W, Robitaille MC, Merrill M, Teferra K, Kim C, Raphael MP. Mechanisms of cell damage due to mechanical impact: an in vitro investigation. Sci Rep. 2020;10(1):12009. Published 2020 Jul 20. https://doi.org/10.1038/s41598-020-68655-2.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Korpacheva OV, Dolgikh VT. Principle energy substrate changing as a technique myocardium of protection against ischemic damage in experimental mechanic cardiac contusion. Pathological physiology and experimental therapy. 2008;4:16-19. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Korpacheva OV, Dolgikh VT. Principle energy substrate changing as a technique myocardium of protection against ischemic damage in experimental mechanic cardiac contusion. Pathological physiology and experimental therapy. 2008;4:16-19. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Li X, Wang Z, Yang Y, Meng F, He Y, Yang P. Myocardial infarction following a blunt chest trauma: A case report. Medicine (Baltimore). 2019;98(4):e14103. https://doi.org/10.1097/MD.0000000000014103.</mixed-citation><mixed-citation xml:lang="en">Li X, Wang Z, Yang Y, Meng F, He Y, Yang P. Myocardial infarction following a blunt chest trauma: A case report. Medicine (Baltimore). 2019;98(4):e14103. https://doi.org/10.1097/MD.0000000000014103.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21(5):268-283. https://doi.org/10.1038/s41580-020-0227-y.</mixed-citation><mixed-citation xml:lang="en">Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21(5):268-283. https://doi.org/10.1038/s41580-020-0227-y.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Prikhodko VA, Selizarova NO, Okovityi SV. Molecular mechanisms for hypoxia development and adaptation to it. Part I. Russian journal of Archive of Pathology. 2021;83(2):52-61 (In Russ.). https://doi.org/10.17116/patol20218302152.</mixed-citation><mixed-citation xml:lang="en">Prikhodko VA, Selizarova NO, Okovityi SV. Molecular mechanisms for hypoxia development and adaptation to it. Part I. Russian journal of Archive of Pathology. 2021;83(2):52-61 (In Russ.). https://doi.org/10.17116/patol20218302152.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Senoner T, Dichtl W. Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?. Nutrients. 2019;11(9):2090. https://doi.org/10.3390/nu11092090.</mixed-citation><mixed-citation xml:lang="en">Senoner T, Dichtl W. Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?. Nutrients. 2019;11(9):2090. https://doi.org/10.3390/nu11092090.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Priymak AB, Korpacheva OV, Zolotov AN, Kluchnikova EI. Dalargin, a peripheral opiate receptor agonist, in the pathogenesis of myocardial contusion in rats with different stress tolerance. Fundamental and clinical medicine. 2022;7(2):8-19 (In Russ.). https://doi.org/10.23946/2500-0764-2022-7-2-8-19.</mixed-citation><mixed-citation xml:lang="en">Priymak AB, Korpacheva OV, Zolotov AN, Kluchnikova EI. Dalargin, a peripheral opiate receptor agonist, in the pathogenesis of myocardial contusion in rats with different stress tolerance. Fundamental and clinical medicine. 2022;7(2):8-19 (In Russ.). https://doi.org/10.23946/2500-0764-2022-7-2-8-19.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Smith KA, Waypa GB, Schumacker PT. Redox signaling during hypoxia in mammalian cells. RedoxBiol. 2017;13:228-234. https://doi.org/10.1016/j.redox.2017.05.020.</mixed-citation><mixed-citation xml:lang="en">Smith KA, Waypa GB, Schumacker PT. Redox signaling during hypoxia in mammalian cells. RedoxBiol. 2017;13:228-234. https://doi.org/10.1016/j.redox.2017.05.020.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Korpacheva OV, Dolgikh VT. Posttraumatic period in cardiac contusion (experimental study). General reanimatology.2008;4(1):13-17 (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Korpacheva OV, Dolgikh VT. Posttraumatic period in cardiac contusion (experimental study). General reanimatology.2008;4(1):13-17 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Korpacheva OV. Vegetative regulation of cardiac activity in an yearly post-traumatic period following experimental heart contusion. Bulletin of the St. Petersburg state medical academy named after I.I. Mechnikov. 2007;8(3):107-109 (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Korpacheva OV. Vegetative regulation of cardiac activity in an yearly post-traumatic period following experimental heart contusion. Bulletin of the St. Petersburg state medical academy named after I.I. Mechnikov. 2007;8(3):107-109 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Korpacheva OV, Dolgikh VT. Electrocardiographic abnormalities in cardiac contusion: experimental study. General reanimatology. 2006;2(5-6):29-34 (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Korpacheva OV, Dolgikh VT. Electrocardiographic abnormalities in cardiac contusion: experimental study. General reanimatology. 2006;2(5-6):29-34 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">de Lucia C, Piedepalumbo M, Paolisso G, Koch WJ. Sympathetic nervous system in age-related cardiovascular dysfunction: Pathophysiology and therapeutic perspective. Int J Biochem Cell Biol. 2019;108:29-33. https://doi.org/10.1016/j.biocel.2019.01.004.</mixed-citation><mixed-citation xml:lang="en">de Lucia C, Piedepalumbo M, Paolisso G, Koch WJ. Sympathetic nervous system in age-related cardiovascular dysfunction: Pathophysiology and therapeutic perspective. Int J Biochem Cell Biol. 2019;108:29-33. https://doi.org/10.1016/j.biocel.2019.01.004.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Atrooz F, Alkadhi KA, Salim S. Understanding stress: Insights from rodent models. Curr Res Neurobiol. 2021;2:100013. https://doi.org/10.1016/j.crneur.2021.100013.</mixed-citation><mixed-citation xml:lang="en">Atrooz F, Alkadhi KA, Salim S. Understanding stress: Insights from rodent models. Curr Res Neurobiol. 2021;2:100013. https://doi.org/10.1016/j.crneur.2021.100013.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Byalovskij YY, Bulatetskii SV, Glushkova EP. Systemic organization of nonspecific adaptation mechanisms in rehabilitation medicine. Voronezh: Limited Liability Company «Izdatelstvo Ritm»;2017. 406 p. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Byalovskij YY, Bulatetskii SV, Glushkova EP. Systemic organization of nonspecific adaptation mechanisms in rehabilitation medicine. Voronezh: Limited Liability Company «Izdatelstvo Ritm»;2017. 406 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Bangsumruaj J, Kijtawornrat A, Kalandakanond-Thongsong S. Effects of chronic mild stress on GABAergic system in the paraventricular nucleus of hypothalamus associated with cardiac autonomic activity. Behav Brain Res. 2022;432:113985. https://doi.org/10.1016/j.bbr.2022.113985.</mixed-citation><mixed-citation xml:lang="en">Bangsumruaj J, Kijtawornrat A, Kalandakanond-Thongsong S. Effects of chronic mild stress on GABAergic system in the paraventricular nucleus of hypothalamus associated with cardiac autonomic activity. Behav Brain Res. 2022;432:113985. https://doi.org/10.1016/j.bbr.2022.113985.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Jie F, Yin G, Yang W, et al. Stress in Regulation of GABA Amygdala System and Relevance to Neuropsychiatric Diseases. Front Neurosci. 2018;12:562. https://doi.org/10.3389/fnins.2018.00562.</mixed-citation><mixed-citation xml:lang="en">Jie F, Yin G, Yang W, et al. Stress in Regulation of GABA Amygdala System and Relevance to Neuropsychiatric Diseases. Front Neurosci. 2018;12:562. https://doi.org/10.3389/fnins.2018.00562.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Wang S. Historical Review: Opiate Addiction and Opioid Receptors. Cell Transplant. 2019;28(3):233-238. https://doi.org/10.1177/0963689718811060.</mixed-citation><mixed-citation xml:lang="en">Wang S. Historical Review: Opiate Addiction and Opioid Receptors. Cell Transplant. 2019;28(3):233-238. https://doi.org/10.1177/0963689718811060.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Stein C. Opioid Receptors. Annu Rev Med. 2016;67:433-51. https://doi.org/10.1146/annurev-med-062613-093100.</mixed-citation><mixed-citation xml:lang="en">Stein C. Opioid Receptors. Annu Rev Med. 2016;67:433-51. https://doi.org/10.1146/annurev-med-062613-093100.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Caruso A, Gaetano A, Scaccianoce S. Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities. Biology (Basel). 2022;11(12):1785. https://doi.org/10.3390/biology11121785.</mixed-citation><mixed-citation xml:lang="en">Caruso A, Gaetano A, Scaccianoce S. Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities. Biology (Basel). 2022;11(12):1785. https://doi.org/10.3390/biology11121785.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Jaschke N, Pählig S, Pan YX, Hofbauer LC, Göbel A, Rachner TD. From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks. Trends Endocrinol Metab. 2021;32(5):306-319. https://doi.org/10.1016/j.tem.2021.02.004.</mixed-citation><mixed-citation xml:lang="en">Jaschke N, Pählig S, Pan YX, Hofbauer LC, Göbel A, Rachner TD. From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks. Trends Endocrinol Metab. 2021;32(5):306-319. https://doi.org/10.1016/j.tem.2021.02.004.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Parker KE, Sugiarto E, Taylor AMW, Pradhan AA, Al-Hasani R. Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease. Mol Pharmacol. 2020;98(4):433-444. https://doi.org/10.1124/mol.120.119438.</mixed-citation><mixed-citation xml:lang="en">Parker KE, Sugiarto E, Taylor AMW, Pradhan AA, Al-Hasani R. Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease. Mol Pharmacol. 2020;98(4):433-444. https://doi.org/10.1124/mol.120.119438.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Patrono C. Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective. Br J Clin Pharmacol. 2016;82(4):957-964. https://doi.org/10.1111/bcp.13048.</mixed-citation><mixed-citation xml:lang="en">Patrono C. Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective. Br J Clin Pharmacol. 2016;82(4):957-964. https://doi.org/10.1111/bcp.13048.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Gądek-Michalska A, Tadeusz J, Rachwalska P, Bugajski J. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems. Pharmacol Rep. 2013;65(6):1655-62. https://doi.org/10.1016/s1734-1140(13)71527-5.</mixed-citation><mixed-citation xml:lang="en">Gądek-Michalska A, Tadeusz J, Rachwalska P, Bugajski J. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems. Pharmacol Rep. 2013;65(6):1655-62. https://doi.org/10.1016/s1734-1140(13)71527-5.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Zolotov AN, Klyuchnikova EI, Korpacheva OV, Priymak AB. Myocardial contractile function in the post-traumatic period of cardiac contusion in rats with different stress resistance: a preclinical experimental randomized trial. Kuban scientific medical bulletin. 2024;31(5):41-72 (In Russ.). https://doi.org/10.25207/1608-6228-2024-31-5-41-72.</mixed-citation><mixed-citation xml:lang="en">Zolotov AN, Klyuchnikova EI, Korpacheva OV, Priymak AB. Myocardial contractile function in the post-traumatic period of cardiac contusion in rats with different stress resistance: a preclinical experimental randomized trial. Kuban scientific medical bulletin. 2024;31(5):41-72 (In Russ.). https://doi.org/10.25207/1608-6228-2024-31-5-41-72.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Klyuchnikova EI, Korpacheva OV, Mozgovoi SI, Zolotov AN, Kononov AV. Expression of Beclin-1 and Caspase-3 after the myocardial contusion in rats with high and low stress resistance. Fundamental and clinical medicine. 2024;9(2):8-19 (In Russ.). https://doi.org/10.23946/2500-0764-2024-9-2-8-19.</mixed-citation><mixed-citation xml:lang="en">Klyuchnikova EI, Korpacheva OV, Mozgovoi SI, Zolotov AN, Kononov AV. Expression of Beclin-1 and Caspase-3 after the myocardial contusion in rats with high and low stress resistance. Fundamental and clinical medicine. 2024;9(2):8-19 (In Russ.). https://doi.org/10.23946/2500-0764-2024-9-2-8-19.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Klyuchnikova EI, Mozgovoy SI, Zolotov AN, Korpacheva OV, Kononov AV. Expression of desmin in the myocardium of rats with high and low stress resistance in the posttraumatic period of cardiac contusion. Modern problems of science and education. 2025;1:36 (In Russ.). https://doi.org/10.17513/spno.33940.</mixed-citation><mixed-citation xml:lang="en">Klyuchnikova EI, Mozgovoy SI, Zolotov AN, Korpacheva OV, Kononov AV. Expression of desmin in the myocardium of rats with high and low stress resistance in the posttraumatic period of cardiac contusion. Modern problems of science and education. 2025;1:36 (In Russ.). https://doi.org/10.17513/spno.33940.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Li J, Li Y, Liu Y et al. Fibroblast Growth Factor 21 Ameliorates NaV1.5 and Kir2.1 Channel Dysregulation in Human AC16 Cardiomyocytes. Front Pharmacol. 2021;12:715466. https://doi.org/10.3389/fphar.2021.715466.</mixed-citation><mixed-citation xml:lang="en">Li J, Li Y, Liu Y et al. Fibroblast Growth Factor 21 Ameliorates NaV1.5 and Kir2.1 Channel Dysregulation in Human AC16 Cardiomyocytes. Front Pharmacol. 2021;12:715466. https://doi.org/10.3389/fphar.2021.715466.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Li J, Gong L, Zhang R et al. Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1. Eur J Pharmacol. 2021;910:174470. https://doi.org/10.1016/j.ejphar.2021.174470.</mixed-citation><mixed-citation xml:lang="en">Li J, Gong L, Zhang R et al. Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1. Eur J Pharmacol. 2021;910:174470. https://doi.org/10.1016/j.ejphar.2021.174470.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Li J, Xu C, Liu Y et al. Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis. Basic Res Cardiol. 2020;115(2):9. https://doi.org/10.1007/s00395-019-0768-4.</mixed-citation><mixed-citation xml:lang="en">Li J, Xu C, Liu Y et al. Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis. Basic Res Cardiol. 2020;115(2):9. https://doi.org/10.1007/s00395-019-0768-4.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Korpacheva OV, Dolgikh VT. Trimetazidine preinjection influence on isolated hearts posttraumatic contractility course of myocardial contusion. Journal of Ural Medical Academic Science. 2008;3(21):37-41 (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Korpacheva OV, Dolgikh VT. Trimetazidine preinjection influence on isolated hearts posttraumatic contractility course of myocardial contusion. Journal of Ural Medical Academic Science. 2008;3(21):37-41 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Mazina NK, Mazin VP, Kovalenko AL. Clinical economic effects of reamberin use in urgent disorders based on results of meta-analysis. Pharmacoeconomics: theory and practice. 2014;2(4):18-25 (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Mazina NK, Mazin VP, Kovalenko AL. Clinical economic effects of reamberin use in urgent disorders based on results of meta-analysis. Pharmacoeconomics: theory and practice. 2014;2(4):18-25 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Oynotkinova OSh, Kornienko EA. Effects of reamberin infusion on dynamic changes in oxidative stress and blood rheological properties in patients with acute myocardial infarction and type 2 diabetes mellitus after percutaneous transluminal angioplasty. FOCUS Endocrinology. 2021;2(2):31-37 (In Russ.). https://doi.org/10.47407/ef2021.2.2.0022.</mixed-citation><mixed-citation xml:lang="en">Oynotkinova OSh, Kornienko EA. Effects of reamberin infusion on dynamic changes in oxidative stress and blood rheological properties in patients with acute myocardial infarction and type 2 diabetes mellitus after percutaneous transluminal angioplasty. FOCUS Endocrinology. 2021;2(2):31-37 (In Russ.). https://doi.org/10.47407/ef2021.2.2.0022.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Gorbunova AV, Dzhabrailova BA, Korpacheva OV. The use of metabolic cytoprotectors trimetazidine and glutamine in experimental cardiac contusion. International research journal. 2016;2-3(44):49-51 (In Russ.). https://doi.org/10.18454/IRJ.2016.44.051.</mixed-citation><mixed-citation xml:lang="en">Gorbunova AV, Dzhabrailova BA, Korpacheva OV. The use of metabolic cytoprotectors trimetazidine and glutamine in experimental cardiac contusion. International research journal. 2016;2-3(44):49-51 (In Russ.). https://doi.org/10.18454/IRJ.2016.44.051.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Abbasov AK, Abbasova DB, Ariphodzhaeva FZ. Efficacy of complex therapy with mildronate in patients with acute coronary syndrome. Molodoi uchyonyi = Young Scientist. 2017;12(146):111-114 (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Abbasov AK, Abbasova DB, Ariphodzhaeva FZ. Efficacy of complex therapy with mildronate in patients with acute coronary syndrome. Molodoi uchyonyi = Young Scientist. 2017;12(146):111-114 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Sidorenko GI, Gelis LG, Medvedeva EA et al. Pharmacological protection of the myocardium with reamberin in coronary artery bypass grafting in patients with postinfarction angina. Terapevticheskii arkhiv. 2011;83(9):35-40 (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Sidorenko GI, Gelis LG, Medvedeva EA et al. Pharmacological protection of the myocardium with reamberin in coronary artery bypass grafting in patients with postinfarction angina. Terapevticheskii arkhiv. 2011;83(9):35-40 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Woxholt S, Ueland T, Aukrust P et al. Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI. Int J Cardiol. 2025;418:132613. https://doi.org/10.1016/j.ijcard.2024.132613.</mixed-citation><mixed-citation xml:lang="en">Woxholt S, Ueland T, Aukrust P et al. Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI. Int J Cardiol. 2025;418:132613. https://doi.org/10.1016/j.ijcard.2024.132613.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Kindberg KM, Broch K, Andersen GØ et al. Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size. JACC Adv. 2024;3(9):101193. https://doi.org/10.1016/j.jacadv.2024.101193.</mixed-citation><mixed-citation xml:lang="en">Kindberg KM, Broch K, Andersen GØ et al. Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size. JACC Adv. 2024;3(9):101193. https://doi.org/10.1016/j.jacadv.2024.101193.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Broch K, Anstensrud AK, Woxholt S et al. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2021;77(15):1845-1855. https://doi.org/10.1016/j.jacc.2021.02.049</mixed-citation><mixed-citation xml:lang="en">Broch K, Anstensrud AK, Woxholt S et al. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2021;77(15):1845-1855. https://doi.org/10.1016/j.jacc.2021.02.049</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Helseth R, Kleveland O, Ueland T et al. Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction. Open Heart. 2021;8(1):e001492. https://doi.org/10.1136/openhrt-2020-001492.</mixed-citation><mixed-citation xml:lang="en">Helseth R, Kleveland O, Ueland T et al. Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction. Open Heart. 2021;8(1):e001492. https://doi.org/10.1136/openhrt-2020-001492.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Wang S, Zhang J, Wang Y, Jiang X, Guo M, Yang Z. NLRP3 inflammasome as a novel therapeutic target for heart failure. Anatol J Cardiol. 2022;26(1):15-22. https://doi.org/10.5152/AnatolJCardiol.2021.580.</mixed-citation><mixed-citation xml:lang="en">Wang S, Zhang J, Wang Y, Jiang X, Guo M, Yang Z. NLRP3 inflammasome as a novel therapeutic target for heart failure. Anatol J Cardiol. 2022;26(1):15-22. https://doi.org/10.5152/AnatolJCardiol.2021.580.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Pavillard LE, Cañadas-Lozano D, Alcocer-Gómez E, et al. NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction. Oncotarget. 2017;8(59):99740-99756. https://doi.org/10.18632/oncotarget.20763.</mixed-citation><mixed-citation xml:lang="en">Pavillard LE, Cañadas-Lozano D, Alcocer-Gómez E, et al. NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction. Oncotarget. 2017;8(59):99740-99756. https://doi.org/10.18632/oncotarget.20763.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Masson W, Lobo M, Barbagelata L, Lavalle-Cobo A, Molinero G. Prognostic value of statin therapy in patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): a meta-analysis. Acta Cardiol. 2022;77(6):480-487. https://doi.org/10.1080/00015385.2021.1955480.</mixed-citation><mixed-citation xml:lang="en">Masson W, Lobo M, Barbagelata L, Lavalle-Cobo A, Molinero G. Prognostic value of statin therapy in patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): a meta-analysis. Acta Cardiol. 2022;77(6):480-487. https://doi.org/10.1080/00015385.2021.1955480.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Stähli BE, Klingenberg R, Heg D et al. Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2022;80(19):1802-1814. https://doi.org/10.1016/j.jacc.2022.08.747.</mixed-citation><mixed-citation xml:lang="en">Stähli BE, Klingenberg R, Heg D et al. Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2022;80(19):1802-1814. https://doi.org/10.1016/j.jacc.2022.08.747.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Aisa Z, Liao GC, Shen XL, Chen J, Jiang SB. Effect of autophagy on myocardial infarction and its mechanism. Eur Rev Med Pharmacol Sci. 2017;21(16):3705-3713.</mixed-citation><mixed-citation xml:lang="en">Aisa Z, Liao GC, Shen XL, Chen J, Jiang SB. Effect of autophagy on myocardial infarction and its mechanism. Eur Rev Med Pharmacol Sci. 2017;21(16):3705-3713.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Li ZH, Wang YL, Wang HJ, Wu JH, Tan YZ. Rapamycin-Preactivated Autophagy Enhances Survival and Differentiation of Mesenchymal Stem Cells After Transplantation into Infarcted Myocardium. Stem Cell Rev Rep. 2020;16(2):344-356. https://doi.org/10.1007/s12015-020-09952-1.</mixed-citation><mixed-citation xml:lang="en">Li ZH, Wang YL, Wang HJ, Wu JH, Tan YZ. Rapamycin-Preactivated Autophagy Enhances Survival and Differentiation of Mesenchymal Stem Cells After Transplantation into Infarcted Myocardium. Stem Cell Rev Rep. 2020;16(2):344-356. https://doi.org/10.1007/s12015-020-09952-1.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Kwon SP, Hwang BH, Park EH et al. Nanoparticle-Mediated Blocking of Excessive Inflammation for Prevention of Heart Failure Following Myocardial Infarction. Small. 2021;17(32):e2101207. https://doi.org/10.1002/smll.202101207.</mixed-citation><mixed-citation xml:lang="en">Kwon SP, Hwang BH, Park EH et al. Nanoparticle-Mediated Blocking of Excessive Inflammation for Prevention of Heart Failure Following Myocardial Infarction. Small. 2021;17(32):e2101207. https://doi.org/10.1002/smll.202101207.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Elma B, Mammadov R, Süleyman H, et al. The effect of rutin on experimentally induced acute heart contusion in rats: Biochemical and histopathological evaluation. Ulus Travma Acil Cerrahi Derg. 2022;28(8):1073-1081. https://doi.org/10.14744/tjtes.2021.97760.</mixed-citation><mixed-citation xml:lang="en">Elma B, Mammadov R, Süleyman H, et al. The effect of rutin on experimentally induced acute heart contusion in rats: Biochemical and histopathological evaluation. Ulus Travma Acil Cerrahi Derg. 2022;28(8):1073-1081. https://doi.org/10.14744/tjtes.2021.97760.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Biffl WL, Fawley JA, Mohan RC. Diagnosis and management of blunt cardiac injury: What you need to know. J Trauma Acute Care Surg. 2024;96(5):685-693. https://doi.org/10.1097/TA.0000000000004216.</mixed-citation><mixed-citation xml:lang="en">Biffl WL, Fawley JA, Mohan RC. Diagnosis and management of blunt cardiac injury: What you need to know. J Trauma Acute Care Surg. 2024;96(5):685-693. https://doi.org/10.1097/TA.0000000000004216.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Oliver E, Mayor F Jr, D’Ocon P. Beta-blockers: Historical Perspective and Mechanisms of Action. Rev Esp Cardiol (Engl Ed). 2019;72(10):853-862. https://doi.org/10.1016/j.rec.2019.04.006.</mixed-citation><mixed-citation xml:lang="en">Oliver E, Mayor F Jr, D’Ocon P. Beta-blockers: Historical Perspective and Mechanisms of Action. Rev Esp Cardiol (Engl Ed). 2019;72(10):853-862. https://doi.org/10.1016/j.rec.2019.04.006.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Wang SY, Shu Q, Chen PP, et al. [Effects of electroacupuncture pretreatment on GABAA receptor of fastigial nucleus and sympathetic nerve activity in rats with myocardial ischemia reperfusion injury]. Zhongguo Zhen Jiu. 2023;43(6):669-678 (In Chin.). https://doi.org/10.13703/j.0255-2930.20221203-k0003.</mixed-citation><mixed-citation xml:lang="en">Wang SY, Shu Q, Chen PP, et al. [Effects of electroacupuncture pretreatment on GABAA receptor of fastigial nucleus and sympathetic nerve activity in rats with myocardial ischemia reperfusion injury]. Zhongguo Zhen Jiu. 2023;43(6):669-678 (In Chin.). https://doi.org/10.13703/j.0255-2930.20221203-k0003.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Antonova VV, Evseev AK, Goroncharovskaya IV et al. The effect of a tyrosyl-d-alanyl-glycyl-phenylalanyl-leucyl-arginine diacetate (Dalargin) on oxidative stress in patients with severe combined trauma: a prospective clinical study. Annals of critical care. 2023;4:185-196 (In Russ.). https://doi.org/10.21320/1818-474X-2023-4-185-196.</mixed-citation><mixed-citation xml:lang="en">Antonova VV, Evseev AK, Goroncharovskaya IV et al. The effect of a tyrosyl-d-alanyl-glycyl-phenylalanyl-leucyl-arginine diacetate (Dalargin) on oxidative stress in patients with severe combined trauma: a prospective clinical study. Annals of critical care. 2023;4:185-196 (In Russ.). https://doi.org/10.21320/1818-474X-2023-4-185-196.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Headrick JP, Pepe S, Peart JN. Non-analgesic effects of opioids: cardiovascular effects of opioids and their receptor systems. Curr Pharm Des. 2012;18(37):60906100. https://doi.org/10.2174/138161212803582360.</mixed-citation><mixed-citation xml:lang="en">Headrick JP, Pepe S, Peart JN. Non-analgesic effects of opioids: cardiovascular effects of opioids and their receptor systems. Curr Pharm Des. 2012;18(37):60906100. https://doi.org/10.2174/138161212803582360.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Olianas MC, Dedoni S, Onali P. δ-Opioid receptors stimulate GLUT1-mediated glucose uptake through Src- and IGF-1 receptor-dependent activation of PI3-kinase signalling in CHO cells. Br J Pharmacol. 2011;163(3):624-637. https://doi.org/10.1111/j.1476-5381.2011.01234.x.</mixed-citation><mixed-citation xml:lang="en">Olianas MC, Dedoni S, Onali P. δ-Opioid receptors stimulate GLUT1-mediated glucose uptake through Src- and IGF-1 receptor-dependent activation of PI3-kinase signalling in CHO cells. Br J Pharmacol. 2011;163(3):624-637. https://doi.org/10.1111/j.1476-5381.2011.01234.x.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Lackner I, Weber B, Knecht D, et al. Cardiac Glucose and Fatty Acid Transport After Experimental Mono- and Polytrauma. Shock. 2020;53(5):620-629. https://doi.org/10.1097/SHK.0000000000001400.</mixed-citation><mixed-citation xml:lang="en">Lackner I, Weber B, Knecht D, et al. Cardiac Glucose and Fatty Acid Transport After Experimental Mono- and Polytrauma. Shock. 2020;53(5):620-629. https://doi.org/10.1097/SHK.0000000000001400.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Bulgakov SA. The use of agonists of opioid peptide receptors in the gastroenterological practice. Russian Journal of Evidence-Based Gastroenterology. 2015;4(1):14-18. (In Russ.). https://doi.org/10.17116/dokgastro201541-214-18.</mixed-citation><mixed-citation xml:lang="en">Bulgakov SA. The use of agonists of opioid peptide receptors in the gastroenterological practice. Russian Journal of Evidence-Based Gastroenterology. 2015;4(1):14-18. (In Russ.). https://doi.org/10.17116/dokgastro201541-214-18.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Perevedentseva SE, Savinova NV, Trofimova SR. The effect of dalargin on the parameters of collagen metabolism in tissues of rats under the action of repeated stress. Health, demography, ecology of the Finno-Ugric peoples. 2022;2:54-58 (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Perevedentseva SE, Savinova NV, Trofimova SR. The effect of dalargin on the parameters of collagen metabolism in tissues of rats under the action of repeated stress. Health, demography, ecology of the Finno-Ugric peoples. 2022;2:54-58 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Liashev AYu, Mal GS. Effect of dalargin on phagocytic activity of neutrophils in the experimental ulcerative colitis in mice. Vestnik of the Smolensk state medical academy. 2024;23(3):40-46 (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Liashev AYu, Mal GS. Effect of dalargin on phagocytic activity of neutrophils in the experimental ulcerative colitis in mice. Vestnik of the Smolensk state medical academy. 2024;23(3):40-46 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y, Li Y, Huang L et al. Antioxidative Stress: Inhibiting Reactive Oxygen Species Production as a Cause of Radioresistance and Chemoresistance. Oxid Med Cell Longev. 2021;2021:6620306. https://doi.org/10.1155/2021/6620306.</mixed-citation><mixed-citation xml:lang="en">Chen Y, Li Y, Huang L et al. Antioxidative Stress: Inhibiting Reactive Oxygen Species Production as a Cause of Radioresistance and Chemoresistance. Oxid Med Cell Longev. 2021;2021:6620306. https://doi.org/10.1155/2021/6620306.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Hu T, Zou HX, Le SY et al. Tanshinone IIA confers protection against myocardial ischemia/reperfusion injury by inhibiting ferroptosis and apoptosis via VDAC1. Int J Mol Med. 2023;52(5):109. https://doi.org/10.3892/ijmm.2023.5312.</mixed-citation><mixed-citation xml:lang="en">Hu T, Zou HX, Le SY et al. Tanshinone IIA confers protection against myocardial ischemia/reperfusion injury by inhibiting ferroptosis and apoptosis via VDAC1. Int J Mol Med. 2023;52(5):109. https://doi.org/10.3892/ijmm.2023.5312.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng TF, Zhao J, Wu QL et al. Compound Dan Zhi tablet attenuates experimental ischemic stroke via inhibiting platelet activation and thrombus formation. Phytomedicine. 2020;79:153330. https://doi.org/10.1016/j.phymed.2020.153330.</mixed-citation><mixed-citation xml:lang="en">Cheng TF, Zhao J, Wu QL et al. Compound Dan Zhi tablet attenuates experimental ischemic stroke via inhibiting platelet activation and thrombus formation. Phytomedicine. 2020;79:153330. https://doi.org/10.1016/j.phymed.2020.153330.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Ding B, Lin C, Liu Q et al. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro. J Neuroinflammation. 2020;17(1):302. https://doi.org/10.1186/s12974-020-01981-4.</mixed-citation><mixed-citation xml:lang="en">Ding B, Lin C, Liu Q et al. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro. J Neuroinflammation. 2020;17(1):302. https://doi.org/10.1186/s12974-020-01981-4.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Shan X, Xiao Y, Hong B et al. Phytochemical profile and protective effects on myocardial ischaemia-reperfusion injury of sweated and non-sweated Salvia miltiorrhiza. Bge alcoholic extracts. J Pharm Pharmacol. 2022;74(9):1230-1240. https://doi.org/10.1093/jpp/rgac012.</mixed-citation><mixed-citation xml:lang="en">Shan X, Xiao Y, Hong B et al. Phytochemical profile and protective effects on myocardial ischaemia-reperfusion injury of sweated and non-sweated Salvia miltiorrhiza. Bge alcoholic extracts. J Pharm Pharmacol. 2022;74(9):1230-1240. https://doi.org/10.1093/jpp/rgac012.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X, Tian C, Zhang Z et al. Astragaloside IV Inhibits NLRP3 Inflammasome- Mediated Pyroptosis via Activation of Nrf-2/HO-1 Signaling Pathway and Protects against Doxorubicin-Induced Cardiac Dysfunction. Front Biosci (Landmark Ed). 2023;28(3):45. https://doi.org/10.31083/j.fbl2803045.</mixed-citation><mixed-citation xml:lang="en">Chen X, Tian C, Zhang Z et al. Astragaloside IV Inhibits NLRP3 Inflammasome- Mediated Pyroptosis via Activation of Nrf-2/HO-1 Signaling Pathway and Protects against Doxorubicin-Induced Cardiac Dysfunction. Front Biosci (Landmark Ed). 2023;28(3):45. https://doi.org/10.31083/j.fbl2803045.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Han X, Yu T, Chen X, Du Z, Yu M, Xiong J. Effect of Astragalus membranaceus on left ventricular remodeling in HFrEF: a systematic review and meta-analysis. Front Pharmacol. 2024;15:1345797. https://doi.org/10.3389/fphar.2024.1345797.</mixed-citation><mixed-citation xml:lang="en">Han X, Yu T, Chen X, Du Z, Yu M, Xiong J. Effect of Astragalus membranaceus on left ventricular remodeling in HFrEF: a systematic review and meta-analysis. Front Pharmacol. 2024;15:1345797. https://doi.org/10.3389/fphar.2024.1345797.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Yang C, Zhu Q, Chen Y et al. Review of the Protective Mechanism of Curcumin on Cardiovascular Disease. Drug Des Devel Ther. 2024;18:165-192. https://doi.org/10.2147/DDDT.S445555.</mixed-citation><mixed-citation xml:lang="en">Yang C, Zhu Q, Chen Y et al. Review of the Protective Mechanism of Curcumin on Cardiovascular Disease. Drug Des Devel Ther. 2024;18:165-192. https://doi.org/10.2147/DDDT.S445555.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Wang S, Yang X. Eleutheroside E decreases oxidative stress and NF-κB activation and reprograms the metabolic response against hypoxia-reoxygenation injury in H9c2 cells. Int Immunopharmacol. 2020;84:106513. https://doi.org/10.1016/j.intimp.2020.106513.</mixed-citation><mixed-citation xml:lang="en">Wang S, Yang X. Eleutheroside E decreases oxidative stress and NF-κB activation and reprograms the metabolic response against hypoxia-reoxygenation injury in H9c2 cells. Int Immunopharmacol. 2020;84:106513. https://doi.org/10.1016/j.intimp.2020.106513.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Stansbury J, Saunders P, Winston D. Supporting Adrenal Function with Adaptogenic Herbs. Journal of Restorative Medicine. 2012;1(1):76-82.</mixed-citation><mixed-citation xml:lang="en">Stansbury J, Saunders P, Winston D. Supporting Adrenal Function with Adaptogenic Herbs. Journal of Restorative Medicine. 2012;1(1):76-82.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Chen J, Huang Q, Li J et al. Panax ginseng against myocardial ischemia/reperfusion injury: A review of preclinical evidence and potential mechanisms. J Ethnopharmacol. 2023;300:115715. https://doi.org/10.1016/j.jep.2022.115715.</mixed-citation><mixed-citation xml:lang="en">Chen J, Huang Q, Li J et al. Panax ginseng against myocardial ischemia/reperfusion injury: A review of preclinical evidence and potential mechanisms. J Ethnopharmacol. 2023;300:115715. https://doi.org/10.1016/j.jep.2022.115715.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Q, Yao Y, Wang Y et al. Ginsenoside Rb2 inhibits p300-mediated SF3A2 acetylation at lysine 10 to promote Fscn1 alternative splicing against myocardial ischemic/reperfusion injury. J Adv Res. 2024;65:365-379. https://doi.org/10.1016/j.jare.2023.12.012.</mixed-citation><mixed-citation xml:lang="en">Huang Q, Yao Y, Wang Y et al. Ginsenoside Rb2 inhibits p300-mediated SF3A2 acetylation at lysine 10 to promote Fscn1 alternative splicing against myocardial ischemic/reperfusion injury. J Adv Res. 2024;65:365-379. https://doi.org/10.1016/j.jare.2023.12.012.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Sarkar C, Quispe C, Jamaddar S et al. Therapeutic promises of ginkgolide A: A literature-based review. Biomed Pharmacother. 2020;132:110908. https://doi.org/10.1016/j.biopha.2020.110908.</mixed-citation><mixed-citation xml:lang="en">Sarkar C, Quispe C, Jamaddar S et al. Therapeutic promises of ginkgolide A: A literature-based review. Biomed Pharmacother. 2020;132:110908. https://doi.org/10.1016/j.biopha.2020.110908.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Walesiuk A, Trofimiuk E, Braszko JJ. Ginkgo biloba normalizes stress- and corticosterone-induced impairment of recall in rats. Pharmacol Res. 2006;53(2):123-128. https://doi.org/10.1016/j.phrs.2005.09.007.</mixed-citation><mixed-citation xml:lang="en">Walesiuk A, Trofimiuk E, Braszko JJ. Ginkgo biloba normalizes stress- and corticosterone-induced impairment of recall in rats. Pharmacol Res. 2006;53(2):123-128. https://doi.org/10.1016/j.phrs.2005.09.007.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Peng Y, Lin Y, Yu NW, Liao XL, Shi L. [The Clinical Efficacy and Possible Mechanism of Combination Treatment of Cerebral Ischemic Stroke with Ginkgo Biloba Extract and Low-Frequency Repetitive Transcranial Magnetic Stimulation]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2021;52(5):883-889 (In Chin.). https://doi.org/10.12182/20210960202.</mixed-citation><mixed-citation xml:lang="en">Peng Y, Lin Y, Yu NW, Liao XL, Shi L. [The Clinical Efficacy and Possible Mechanism of Combination Treatment of Cerebral Ischemic Stroke with Ginkgo Biloba Extract and Low-Frequency Repetitive Transcranial Magnetic Stimulation]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2021;52(5):883-889 (In Chin.). https://doi.org/10.12182/20210960202.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao X, Xiang Y, Cai C, Zhou A, Zhu N, Zeng C. Schisandrin B protects against myocardial ischemia/reperfusion injury via the PI3K/Akt pathway in rats. Mol Med Rep. 2018;17(1):556-561. https://doi.org/10.3892/mmr.2017.7926.</mixed-citation><mixed-citation xml:lang="en">Zhao X, Xiang Y, Cai C, Zhou A, Zhu N, Zeng C. Schisandrin B protects against myocardial ischemia/reperfusion injury via the PI3K/Akt pathway in rats. Mol Med Rep. 2018;17(1):556-561. https://doi.org/10.3892/mmr.2017.7926.</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Giridharan VV, Thandavarayan RA, Arumugam S et al. Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression. PLoS One. 2015;10(11):e0142483. https://doi.org/10.1371/journal.pone.0142483.</mixed-citation><mixed-citation xml:lang="en">Giridharan VV, Thandavarayan RA, Arumugam S et al. Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression. PLoS One. 2015;10(11):e0142483. https://doi.org/10.1371/journal.pone.0142483.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Yang J, Zhou D, Hu J, Yang DH, Cai Y, Lu Q. Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through AKT-mTOR pathway. Sarcoidosis Vasc Diffuse Lung Dis. 2024;41(3):e2024034. https://doi.org/10.36141/svdld.v41i3.12728.</mixed-citation><mixed-citation xml:lang="en">Yang J, Zhou D, Hu J, Yang DH, Cai Y, Lu Q. Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through AKT-mTOR pathway. Sarcoidosis Vasc Diffuse Lung Dis. 2024;41(3):e2024034. https://doi.org/10.36141/svdld.v41i3.12728.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao A, Liu N, Jiang G et al. Combination of panax ginseng and ginkgo biloba extracts attenuate cerebral ischemia injury with modulation of NLRP3 inflammasome and CAMK4/CREB pathway. Front Pharmacol. 2022;13:980449. https://doi.org/10.3389/fphar.2022.980449.</mixed-citation><mixed-citation xml:lang="en">Zhao A, Liu N, Jiang G et al. Combination of panax ginseng and ginkgo biloba extracts attenuate cerebral ischemia injury with modulation of NLRP3 inflammasome and CAMK4/CREB pathway. Front Pharmacol. 2022;13:980449. https://doi.org/10.3389/fphar.2022.980449.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Cong W, Sheng L, Li Y, Li P, Lin C, Liu J. [Protective effects of ginseng-ginko extracts combination on rat primary cultured neurons induced by Abeta(1-40)]. Zhongguo Zhong Yao Za Zhi. 2011;36(7):908-11 (In Chin.).</mixed-citation><mixed-citation xml:lang="en">Cong W, Sheng L, Li Y, Li P, Lin C, Liu J. [Protective effects of ginseng-ginko extracts combination on rat primary cultured neurons induced by Abeta(1-40)]. Zhongguo Zhong Yao Za Zhi. 2011;36(7):908-11 (In Chin.).</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
